In one paragraphArticle in Clinical and translational science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Suzanne van der GaagDepartment of Radiology and Nuclear Medicine, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.ORCID 0000-0001-7270-7409 Mike J C VeermanDepartment of Clinical Pharmacology and Pharmacy, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.ORCID 0009-0002-0308-7060 Habibe YilmazDepartment of Clinical Pharmacology and Pharmacy, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Jan AmsuDepartment of Clinical Pharmacology and Pharmacy, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Sebastian J V PruijnDepartment of Clinical Pharmacology and Pharmacy, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Daniela E Oprea-LagerDepartment of Radiology and Nuclear Medicine, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.ORCID 0000-0001-9447-2305 Matthijs C F CysouwDepartment of Radiology and Nuclear Medicine, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.ORCID 0000-0001-5946-0173 Bernard H E JansenDepartment of Urology, Prostate Cancer Network Amsterdam, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.ORCID 0000-0003-2107-145X Maqsood M YaqubDepartment of Radiology and Nuclear Medicine, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.ORCID 0000-0003-2122-740X André N VisDepartment of Urology, Prostate Cancer Network Amsterdam, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.ORCID 0000-0003-3419-3368 Harry HendrikseDepartment of Radiology and Nuclear Medicine, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.ORCID 0000-0001-8072-5391 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Prostate-specific membrane antigen (PSMA) is overexpressed in over 90% of prostate cancer tumors, making it a strong target for imaging and therapy. The diagnostic tracer [
Indexed as
DipeptidesHeterocyclic Compounds, 1-RingProstatic NeoplasmsRadiopharmaceuticalsAgedAntigens, SurfaceFluorine RadioisotopesGlutamate Carboxypeptidase IIHumansLutetiumMaleModels, BiologicalPositron-Emission TomographyPositron Emission Tomography Computed TomographyProstate-Specific AntigenRadioisotopesAntigens, SurfaceDipeptidesFluorine RadioisotopesFOLH1 protein, humanGlutamate Carboxypeptidase IIHeterocyclic Compounds, 1-RingLutetiumLutetium-177Prostate-Specific AntigenPSMA-617RadioisotopesRadiopharmaceuticalsimagingmodelingprostate cancerPSMAtherapy
Identifiers
PMID42138316
PMCPMC13177845
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390